Literature DB >> 31693131

Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms.

Hadine Joffe1,2,3, Anouk de Wit1,4, Jamie Coborn1,2, Sybil Crawford5, Marlene Freeman3, Aleta Wiley1, Geena Athappilly1, Semmie Kim1, Kathryn A Sullivan1, Lee S Cohen3, Janet E Hall6.   

Abstract

CONTEXT: Women are at increased risk for depressive symptoms during the menopause transition. Changes in estradiol secretion and presence of vasomotor symptoms (VMS) contribute to perimenopausal depressive symptoms, but links with progesterone have not been investigated.
OBJECTIVE: To determine whether estradiol variability, ovulatory levels of progesterone, and VMS burden are independently associated with perimenopausal depressive symptomatology. DESIGN AND INTERVENTION: Depressive symptoms, serum levels of estradiol and progesterone, and VMS frequency were assessed weekly in an 8-week observational study. Association of mood with estradiol variability, ovulatory levels of progesterone, and VMS frequency were estimated using generalized estimating equation models.
SETTING: Academic medical center. PATIENTS: Fifty unmedicated perimenopausal women with mild-to-moderate depressive symptoms (mean Montgomery-Åsberg Depression Rating Scale [MADRS] score 15.5 ± 5.3). MAIN OUTCOME MEASURE: Depressive symptoms (MADRS score).
RESULTS: During the study, 90.0% of participants had varying estradiol levels, 51.1% had ovulatory progesterone levels, and 90% had VMS. Greater estradiol variability and absence of progesterone levels consistent with ovulation, but not VMS frequency, are associated with higher levels of depressive symptoms (β = 0.11 [95% confidence interval (95% CI), 0.04 to 0.18; P = 0.001]; β = -2.62 [95% CI, -4.52 to -0.71; P = 0.007], respectively), after accounting for higher body mass index, lifetime history of depression, and stressful life events.
CONCLUSIONS: Increasing dysregulation of ovarian hormones, but not VMS, associates with more depressive symptom burden during perimenopause. These results suggest that perimenopausal mood instability is driven by the underlying hormonal dysregulation of the menopause transition involving changes in both estradiol and progesterone. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  depression; estradiol; mood; ovulation; perimenopause; progesterone

Mesh:

Substances:

Year:  2020        PMID: 31693131      PMCID: PMC7075107          DOI: 10.1210/clinem/dgz181

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.

Authors:  Samantha Meltzer-Brody; Helen Colquhoun; Robert Riesenberg; C Neill Epperson; Kristina M Deligiannidis; David R Rubinow; Haihong Li; Abdul J Sankoh; Christine Clemson; Amy Schacterle; Jeffrey Jonas; Stephen Kanes
Journal:  Lancet       Date:  2018-08-31       Impact factor: 79.321

2.  Random serum progesterone threshold to confirm ovulation.

Authors:  R Leiva; T Bouchard; H Boehringer; S Abulla; R Ecochard
Journal:  Steroids       Date:  2015-06-22       Impact factor: 2.668

3.  Longitudinal study of hormone levels and depression among women transitioning through menopause.

Authors:  N E Avis; S Crawford; R Stellato; C Longcope
Journal:  Climacteric       Date:  2001-09       Impact factor: 3.005

4.  Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN).

Authors:  J T Bromberger; H M Kravitz; Y-F Chang; J M Cyranowski; C Brown; K A Matthews
Journal:  Psychol Med       Date:  2011-02-09       Impact factor: 7.723

5.  Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis.

Authors:  Simon Gilbody; David Richards; Stephen Brealey; Catherine Hewitt
Journal:  J Gen Intern Med       Date:  2007-09-14       Impact factor: 5.128

6.  Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms.

Authors:  Jennifer L Gordon; David R Rubinow; Rebecca C Thurston; Julia Paulson; Peter J Schmidt; Susan S Girdler
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

7.  A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study.

Authors:  N E Avis; D Brambilla; S M McKinlay; K Vass
Journal:  Ann Epidemiol       Date:  1994-05       Impact factor: 3.797

Review 8.  A reproductive subtype of depression: conceptualizing models and moving toward etiology.

Authors:  Jennifer L Payne; Jennifer Teitelbaum Palmer; Hadine Joffe
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

9.  Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Kathleen Smith-DiJulio; Donald B Percival; Eunice Y Tao; Anne Mariella; Sullivan Mitchell
Journal:  Menopause       Date:  2008 Mar-Apr       Impact factor: 2.953

10.  Naturally Occurring Changes in Estradiol Concentrations in the Menopause Transition Predict Morning Cortisol and Negative Mood in Perimenopausal Depression.

Authors:  Jennifer L Gordon; Tory A Eisenlohr-Moul; David R Rubinow; Leah Schrubbe; Susan S Girdler
Journal:  Clin Psychol Sci       Date:  2016-09
View more
  5 in total

1.  Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles.

Authors:  Jamie Coborn; Anouk de Wit; Sybil Crawford; Margo Nathan; Shadab Rahman; Lauren Finkelstein; Aleta Wiley; Hadine Joffe
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

2.  Brain-derived neurotrophic factor and mood in perimenopausal depression.

Authors:  Jessica A Harder; Raina N Fichorova; Akanksha Srivastava; Aleta Wiley; Katherine E Burdick; Joseph J Locascio; Hadine Joffe
Journal:  J Affect Disord       Date:  2021-12-23       Impact factor: 4.839

3.  Changes in the regional homogeneity of resting-state magnetic resonance imaging in perimenopausal women.

Authors:  Min Liu; Hui Yang; Jian Qin; Qianqian Yao; Guihua Yang; Jiang Li
Journal:  BMC Womens Health       Date:  2021-01-28       Impact factor: 2.809

4.  Reduced Plasma Estradiol Levels are Associated with Sleep Apnea in Depressed Peri- and Post-Menopausal Women.

Authors:  Li-Qiang Cai; Lei Huang; Li-Li Wei; Jia-Shu Yao; Luo-Yi Xu; Wei Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-02       Impact factor: 2.570

5.  The Cortisol and ACTH Response to Dex/CRH Testing in Women With and Without Perimenopausal Depression.

Authors:  Gioia M Guerrieri; Rivka Ben Dor; Xiaobai Li; Shau-Ming Wei; Pedro E Martinez; Lynnette K Neiman; David R Rubinow; Peter J Schmidt
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.